2023-10-23 15:56:41
Injector pens of this product diverted for weight loss purposes are falsified and have been identified in European pharmacies.
Ozempic, a treatment for type 2 diabetes misused for weight loss purposes and very popular on social networks, has already caused a lot of ink to flow. But European and French health authorities are now warning of the circulation of injector pens falsely labeled as Ozempic.
« At this stage, no alert has been reported in France »writes the National Medicines Safety Agency (ANSM), but it is « important to check the traceability of the serial number » during dispensing, underlines the ANSM in an information note intended for community and hospital pharmacists. Indeed, according to the European Medicines Agency (EMA), « pre-filled pens falsely labeled as Ozempic (semaglutide, 1mg, solution for injection), have been identified at certain wholesalers in the European Union and the United Kingdom ».
» READ ALSO – Using the antidiabetic Ozempic to lose weight: medical authorities are sounding the alarm
Labeling from Germany
« As a precaution, we call on all actors in the supply chain to be vigilant », specifies the ANSM. These fraudulent pens, bearing labeling from Germany, were identified at distributors in Germany, Austria and the United Kingdom, according to the EMA which explains that there are « differences in appearance between counterfeit pen and genuine pen ». The falsified batches of Ozempic showed inactive serial numbers on the scanner, which triggered the alert.
The situation is currently being investigated by EU medicines regulators and the police, the EMA points out. For now, « there is no indication that falsified pens were dispensed to patients by pharmacies »according to her.
1698293016
#Fraudulent #antidiabetic #injector #pens #circulating #Europe